Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma

American Journal of Surgical Pathology

Volumn 30, Issue 7, 2006, Pages 802-810

  Dorfman, David M ^a   Brown, Julia A ^b,c   Shahsafaei, Aliakbar ^a   Freeman, Gordon J ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CD28 family; Hodgkin lymphoma; Nodular lymphocyte predominant; Non Hodgkin lymphoma

Indexed keywords

CD20 ANTIGEN; CD28 ANTIGEN; CD52 ANTIGEN; CELL MARKER; PROGRAMMED DEATH 1 PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN; TUMOR MARKER;

ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL SUBPOPULATION; CONTROLLED STUDY; DENDRITIC CELL; DIAGNOSTIC VALUE; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; B CELL LYMPHOMA; ENZYME IMMUNOASSAY; IMMUNOBLASTIC LYMPHADENOPATHY; METABOLISM; PATHOLOGY; T LYMPHOCYTE;

ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; GERMINAL CENTER; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOENZYME TECHNIQUES; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 33746877544     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000209855.28282.ce     Document Type: Article

References (20)

1. Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood. 2005;105:13-21.
2. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol. 2002;2:116-126.
3. Probst HC, McCoy K, Okazaki T, et al. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immunol. 2005;6:280-286.
4. Brown J, Dorfman DM, Ma F-R, et al. Blockade of PD-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol. 2003;170:1257-1266.
5. Iwai Y, Okaszaki T, Nishimura H, et al. Microanatomical localization of PD-1 in human tonsils. Immunol Lett. 2002;83:215-220.
6. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:189-235.
7. Jones D, Fletcher CDM, Pulford K, et al. The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma. Blood. 1999;93:3487-3493.
8. Dorfman DM, Greisman HA, Shahsafaei A. Loss of expression of the WNT/Beta-catenin signaling pathway transcription factors lymphoid enhancer protein-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas. Am J Pathol. 2003;162. In press.
9. Chtanova T, Tangye SG, Newton R, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173:68-78.
10. Jones D, O'Hara C, Kraus MD, et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood. 2000;96:685-690.
11. Dorfman DM, van den Elzen P, Weng AP, et al. Differential expression of T-bet, a T box transcription factor required for Th1 T cell development, in peripheral T cell lymphomas. Am J Clin Pathol. 2003;120:866-873.
12. Jones D, Jorgensen JL, Shahsafaei A, et al. Characteristic proliferations of reticular and dendritic cells in angioimmunoblastic lymphoma. Am J Surg Pathol. 1998;22:956-964.
13. Ree HJ, Kadin ME, Kikuchi M, et al. Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. Hum Pathol. 1999;30:403-411.
14. Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002;99:627-633.
15. Arber DA, Weiss LM. CD10: a review. Appl Immunohistdochem. 1997;5:125-140.
16. Dorfman DM, Hwang ES, Shahsafaei A, et al. T-bet, a T-cell-associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders. Am J Clin Pathol. 2004;122:292-297.
17. Marafioti T, Ascani S, Pulford K, et al. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. Am J Pathol. 2003;162:861-871.
18. Braeuninger A, Kuppers R, Strickler JG, et al. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci USA. 1997;94:9337-9342.
19. Marafioti T, Hummel M, Anagnostopoulos I, et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med. 1997;337:453-458.
20. Kim CH, Rott LS, Clark-Lewis I, et al. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J Exp Med. 2001;193:1373.